Posted February 13, 2009
Pfizer
By SIMON KING, Datamonitor
Analysis: Pfizer’s acquisition of Wyeth immediately brings scale but will fail to deliver sustainable sales growth. Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Whopper of a merger for Wyeth, Pfizer – but questionable long-term value
Post a comment
Print this storyE-mail story
Share
Pfizer
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
